Skip to content
10-K

Annual Report

Medpace Holdings, Inc. MEDP

0001668397-25-000017

← back to feed
Filed
Feb 11, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 7, 2025 30.47M sh
Cash And Equivalents FY 2024 · Dec 31, 2023 $245.45M
Current Liabilities FY 2024 · Dec 31, 2023 $925.13M
Total Liabilities FY 2024 · Dec 31, 2023 $1.1B
Current Assets FY 2024 · Dec 31, 2023 $593.83M
Total Assets FY 2024 · Dec 31, 2023 $1.66B
Shares Diluted FY 2024 · Dec 31, 2022 33.67M sh
Stock Repurchased FY 2024 · Dec 31, 2022 $847.85M
Capex FY 2024 · Dec 31, 2022 $36.88M
Operating Cash Flow FY 2024 · Dec 31, 2022 $388.05M
Eps Diluted FY 2024 · Dec 31, 2022 $7.28
Eps Basic FY 2024 · Dec 31, 2022 $7.57
Sga Expense FY 2024 · Dec 31, 2022 $131.4M
Net Income FY 2024 · Dec 31, 2022 $245.37M
Operating Income FY 2024 · Dec 31, 2022 $278.7M
Revenue FY 2024 · Dec 31, 2022 $1.46B
Stockholders Equity FY 2024 · Dec 31, 2021 $952.93M